Riccardo Braglia - 16 Oct 2023 Form 4 Insider Report for Thorne Healthtech, Inc. (THRN)

Role
Director
Signature
/s/ Kim Pearson, under power of attorney
Issuer symbol
THRN
Transactions as of
16 Oct 2023
Net transactions value
$0
Form type
4
Filing time
18 Oct 2023, 16:56:09 UTC
Previous filing
29 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction THRN Common Stock Disposed to Issuer -5,424,550 -100% 0 16 Oct 2023 See Footnote F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction THRN Warrant (Right to buy) Disposed to Issuer $0 -453,455 -100% $0.000000* 0 16 Oct 2023 Common Stock 453,455 $6.74 See Footnote F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Riccardo Braglia is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 At the effective time of the merger (the "Effective Time") contemplated by the Agreement and Plan of Merger between the Issuer, Healthspan Buyer, LLC and Healthspan Merger Sub, Inc., dated as of August 27, 2023 (the "Merger Agreement"), each issued and outstanding share of the Issuer's Common Stock was cancelled and converted into the right to receive an amount equal to $10.20 in cash (the "Per Share Price"), subject to the terms set forth in the Merger Agreement.
F2 The securities are directly held by Helsinn International (U.S.) Corporation ("Helsinn") (formerly ELUS Holdings Corporation). The Reporting Person serves as Chairman of the board of directors of Helsinn and as Chairman of Helsinn's ultimate parent company, Helsinn SA.
F3 At the Effective Time, the warrant was cancelled pursuant to the Merger Agreement in exchange for a cash payment equal to (x) the difference between the Per Share Price and the per share exercise price of the warrant, multiplied by (y) the number of disposed warrant shares.